Please login to the form below

Not currently logged in

Akcea Pharma

This page shows the latest Akcea Pharma news and features for those working in and with pharma, biotech and healthcare.

Despite FDA concerns, Akcea rare disease drug clears FDA panel

Despite FDA concerns, Akcea rare disease drug clears FDA panel

FDA now set to deliver final verdict by 30 August. Akcea Pharma has moved a step closer to commercialising Waylivra, a drug for rare disorder familial chylomicronemia syndrome (FCS), after an ... We believe that these results provide strong support to

Latest news

  • Novartis boosts cardiovascular pipeline with $1bn Ionis deal Novartis boosts cardiovascular pipeline with $1bn Ionis deal

    The new agreement with Ionis subsidiary Akcea Pharma gives Novartis an option to license the two lipoprotein-targeting drugs, which are in early-stage clinical development. ... Novartis is also expected to make a further equity investment of $50m in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...